Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ONO-4685 by Ono Pharmaceutical for Follicular Lymphoma: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
ONO-2808 by Ono Pharmaceutical for Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration): Likelihood of Approval
ONO-2808 is under clinical development by Ono Pharmaceutical and currently in Phase II for Multiple System Atrophy (MSA or Shy-Drager...
ONO-4915 by Ono Pharmaceutical for Autoimmune Disorders: Likelihood of Approval
ONO-4915 is under clinical development by Ono Pharmaceutical and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to...
ONO-4685 by Ono Pharmaceutical for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
ONO-4685 by Ono Pharmaceutical for Mycosis Fungoides: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...
ONO-4685 by Ono Pharmaceutical for Sezary Syndrome: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Sezary Syndrome. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Cutaneous T-Cell Lymphoma: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData,...
ONO-4685 by Ono Pharmaceutical for T-Cell Lymphomas: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for T-Cell Lymphomas. According to GlobalData, Phase...
Nivolumab by Ono Pharmaceutical for Mantle Cell Lymphoma: Likelihood of Approval
Nivolumab is under clinical development by Ono Pharmaceutical and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData,...
ONO-2910 by Ono Pharmaceutical for Diabetic Neuropathy: Likelihood of Approval
ONO-2910 is under clinical development by Ono Pharmaceutical and currently in Phase I for Diabetic Neuropathy. According to GlobalData, Phase...
ONO-2020 by Ono Pharmaceutical for Neurodegenerative Diseases: Likelihood of Approval
ONO-2020 is under clinical development by Ono Pharmaceutical and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase...
ONO-7122 by Ono Pharmaceutical for Solid Tumor: Likelihood of Approval
ONO-7122 is under clinical development by Ono Pharmaceutical and currently in Phase I for Solid Tumor. According to GlobalData, Phase...